Cargando…
Advances of CRISPR-Cas13 system in COVID-19 diagnosis and treatment
The ongoing global pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in over 570 million infections and 6 million deaths worldwide. Early detection and quarantine are essential to arrest the spread of the highly...
Autores principales: | Zhou, Qianqian, Chen, Yanhua, Wang, Ruolei, Jia, Fengjing, He, Feng, Yuan, Fuwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793954/ https://www.ncbi.nlm.nih.gov/pubmed/36591005 http://dx.doi.org/10.1016/j.gendis.2022.11.016 |
Ejemplares similares
-
Potential of CRISPR/Cas13 System in Treatment and Diagnosis of COVID-19
por: Khodavirdipour, Amir, et al.
Publicado: (2021) -
Optimized Antimicrobial Peptide Jelleine-I Derivative Br-J-I Inhibits Fusobacterium Nucleatum to Suppress Colorectal Cancer Progression
por: Jia, Fengjing, et al.
Publicado: (2023) -
Metagenomic discovery of novel CRISPR-Cas13 systems
por: Hu, Yanping, et al.
Publicado: (2022) -
Development of CRISPR/Cas13a-based assays for the diagnosis of Schistosomiasis
por: MacGregor, Skye R., et al.
Publicado: (2023) -
The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)